Kymera Therapeutics (KYMR) Other Non-Current Assets (2019 - 2026)

Kymera Therapeutics (KYMR) has 8 years of Other Non-Current Assets data on file, last reported at $7.7 million in Q1 2026.

• On a quarterly basis, Other Non-Current Assets rose 32.55% year-over-year to $7.7 million in Q1 2026; TTM through Mar 2026 was $7.7 million, a 32.55% increase from a year earlier, with the FY2025 full-year figure at $9.1 million, up 57.3% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $7.7 million, down from $9.1 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for KYMR reached as high as $9.1 million in Q4 2025 and fell as low as $2.0 million in Q1 2022.
• Historically, Other Non-Current Assets has averaged $5.2 million across 5 years, with a median of $5.8 million in 2023.
• Across the five-year window, Other Non-Current Assets soared 284.71% in 2022 and sank 54.19% in 2023, its largest moves.
• Year by year, Other Non-Current Assets stood at $3.0 million in 2022, then retreated by 29.8% to $2.1 million in 2023, then soared by 173.56% to $5.8 million in 2024, then surged by 57.3% to $9.1 million in 2025, then decreased by 15.55% to $7.7 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $7.7 million in Q1 2026, $9.1 million in Q4 2025, and $5.8 million in Q3 2025.